scholarly article | Q13442814 |
P50 | author | John D. Lambris | Q6228220 |
Roselyn J. Eisenberg | Q20675664 | ||
Gary H Cohen | Q88784699 | ||
Harvey M. Friedman | Q89912954 | ||
P2093 | author name string | Ann H Rux | |
Huan Lou | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heparin | Q190016 |
P304 | page(s) | 324-332 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. | |
P478 | volume | 294 |
Q35914367 | A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens |
Q34141544 | Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread |
Q83874921 | Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages |
Q42664630 | Characterization of the gene encoding glycoprotein C of duck enteritis virus |
Q90126817 | Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes |
Q33804431 | Complement Evasion Strategies of Viruses: An Overview |
Q36878921 | Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells |
Q33623972 | Complement evasion by human pathogens |
Q39594070 | Detection of anatid herpesvirus 1 gC gene by TaqMan fluorescent quantitative real-time PCR with specific primers and probe |
Q45710613 | Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3 |
Q34593833 | Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans |
Q90560370 | Drivers and regulators of humoral innate immune responses to infection and cancer |
Q35105400 | Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles |
Q35182202 | Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusion |
Q33788855 | Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. |
Q36925941 | HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. |
Q40581107 | HSV-1 virions engineered for specific binding to cell surface receptors |
Q33987520 | Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry |
Q34545821 | Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. |
Q34345831 | Herpes simplex virus type 1 evades the effects of antibody and complement in vivo |
Q41873760 | Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding |
Q37967568 | Human cytomegalovirus infection and atherothrombosis |
Q45453302 | Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains |
Q33910764 | In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. |
Q43678006 | Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance |
Q33857937 | Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy |
Q38854789 | Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction |
Q57016583 | Multivalent binding of herpesvirus to living cells is tightly regulated during infection |
Q35973512 | Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific |
Q37547107 | Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs |
Q42805655 | Quantitative comparison of the HSV-1 and HSV-2 transcriptomes using DNA microarray analysis. |
Q37415391 | Regulation of HSV glycoprotein induced cascade of events governing cell-cell fusion |
Q24683262 | Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry |
Q24538731 | Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM). |
Q33610941 | The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects. |
Q27488704 | Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans |
Q38995165 | Viral-derived complement inhibitors: current status and potential role in immunomodulation |
Search more.